cabozantinib

Preliminary Data Demonstrate that 40 mg Daily Dose of Cabozantinib Yields a High Rate of Bone Scan Response in mCRPC
Yahoo/BusinessWire
Sun, 11/13/11 - 12:06 pm
prostate cancer
cabozantinib
bone cancer
Exelixis
Five Drugs That Own The Prostate Pipeline
Seeking Alpha
Tue, 11/8/11 - 11:00 am
prostate cancer
Dendreon
Provenge
Zytiga
JNJ
Medivation
MVD 3100
Exelixis
cabozantinib
Curtirsen
Teva Pharmaceuticals
OncoGenex
Exelixis clashes with FDA over prostate cancer study, shares tank
Fierce Biotech
Tue, 11/1/11 - 11:05 am
prostate cancer
FDA
Exelixis
cabozantinib
Biotech Blunder Turned 20% Overnight Gain
Motley Fool
Tue, 10/25/11 - 09:25 am
Exelixis
medullary thyroid cancer
cabozantinib
Exelixis: Thyroid Cancer Drug Delays Tumor Growth
TheStreet.com
Mon, 10/24/11 - 11:38 am
Exelixis
cabozantinib
medullary thyroid cancer
Biotech Calendar: Key Dates for October
TheStreet.com
Mon, 10/3/11 - 11:13 am
biotech
flurosorafenib
ONYX Pharmaceuticals
Bayer
Rigel
Teva Pharmaceuticals
Biogen Idec
BG-12
Heplisav
Amgen
Dynavax
Pacira
Bristol-Myers Squibb
Dapagliflozin
EXPAREL
cabozantinib
Exelixis
Exelixis: Still Promising, Still Controversial
Seeking Alpha
Mon, 08/22/11 - 11:47 am
Exelixis
cabozantinib
Bone metastases
Biotech Gem Exelixis Is Compelling Only for the Long Term
Seeking Alpha
Sat, 08/20/11 - 10:03 pm
Exelixis
cabozantinib
XL184
The Tale of 2 Drug Handbacks
Motley Fool
Mon, 07/18/11 - 05:33 pm
Exelixis
Bristol-Myers Squibb
cabozantinib
XL-281
The Good, Bad, and Ugly of Exelixis' Drug Delay
Motley Fool
Thu, 07/7/11 - 10:11 pm
Exelixis
thyroid cancer
cabozantinib
Exelixis Delays Results of Cancer Drug Study
Minyanville
Thu, 07/7/11 - 12:06 pm
Exelixis
cabozantinib
thyroid cancer
ASCO '11: Exelixis Updates Prostate Cancer Data
TheStreet.com
Mon, 06/6/11 - 09:28 pm
Exelixis
prostate cancer
ASCO
cabozantinib
Exelixis Drug Shrinks Ovarian Cancer
The Street
Sun, 06/5/11 - 10:06 am
Exelixis
cabozantinib
ovarian cancer
5 Biotechs With Upcoming Clinical Trial Results
Motley Fool
Wed, 06/1/11 - 07:52 am
Amarin
AMR101
cabozantinib
Exelixis
HIV quad pill
Gilead Sciences
Medivation
MDV3100
Astellas
Vical
skin cancer
YM BioSciences
nimotuzumab
Exelixis keeps cards close
Minyanville
Thu, 05/19/11 - 01:53 pm
Exelixis
cabozantinib
Ariad and Exelixis Look to Shine at Upcoming Trade Show
Seeking Alpha
Thu, 05/12/11 - 11:48 am
Ariad Pharmaceuticals
Exelixis
ridaforolimus
cancer
cabozantinib
Exelixis spurs takeover rumors with Goldman ploy
Fierce Biotech
Tue, 04/12/11 - 10:17 am
prostate cancer
Exelixis
cabozantinib
10 promising late-stage cancer drugs
Fierce Biotech
Tue, 04/5/11 - 10:47 pm
cancer
Carfilzomib
crizotinib
vismodegib
Oncovex
PLX4032
Ponatinib
SGN-35
tivozanib
T-DM1
cabozantinib
ONYX Pharmaceuticals
Pfizer
Genentech
Curis
Amgen
Plexxikon
Seattle Genetics
Ariad Pharmaceuticals
Aveo Pharmaceutical
Exelixis
Roche
Exelixis: Going Where No Drug Has Gone Before
Seeking Alpha
Wed, 02/23/11 - 10:47 pm
Exelixis
cabozantinib
prostate cancer
Exelixis shares rise after report on cancer drug
Yahoo/AP
Sat, 02/19/11 - 11:38 am
Exelixis
prostate cancer
cabozantinib

Pages